PepGen (PEPG) director granted 34,000 options for RA Capital funds
Rhea-AI Filing Summary
PepGen Inc. reported that director Joshua Resnick received a grant of stock options covering 34,000 shares of Common Stock at an exercise price of $1.79 per share, expiring on June 17, 2036.
The option vests in full on the earlier of the first anniversary of the grant date or the next Annual Meeting, with vesting stopping if he ceases to serve as a director unless the Board decides otherwise. Under his arrangement with RA Capital Management, L.P., Resnick holds this option for the benefit of RA Capital Healthcare Fund, RA Capital Nexus Fund II, and a separately managed account, must turn over any net cash or stock on exercise to RA Capital, and disclaims beneficial ownership of the option and underlying shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Resnick Joshua
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 34,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 34,000 shares (Direct)
Footnotes (2)
- F1. This option shall vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next Annual Meeting; provided, however, that all vesting shall cease if the individual ceases to serve as a director, unless the Board of Directors determines that the circumstances warrant continuation of vesting.
- F2. Under the Reporting Person's arrangement with RA Capital Management, L.P. (the "Adviser"), the Reporting Person holds the stock option for the benefit of the RA Capital Healthcare Fund, L.P. (the "Fund"), RA Capital Nexus Fund II, L.P. (the "Nexus Fund II"), and a separately managed account (the "Account"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received upon exercise of the stock option, which will offset advisory fees owed by the Fund, the Nexus Fund II, and the Account to the Adviser. The Reporting Person therefore disclaims beneficial ownership of the stock option and underlying Common Stock.
Key Figures
Option grant size: 34,000 options
Exercise price: $1.79 per share
Expiration date: June 17, 2036
+2 more
5 metrics
Option grant size
34,000 options
Stock Option (Right to Buy) granted to Joshua Resnick
Exercise price
$1.79 per share
Conversion or exercise price of granted options
Expiration date
June 17, 2036
Option expiration for Resnick’s grant
Shares underlying options
34,000 shares
Underlying PepGen Common Stock
Post-transaction derivative holdings
34,000 options
Total options held following this grant
Key Terms
Stock Option (Right to Buy), beneficial ownership, Annual Meeting, advisory fees, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
beneficial ownership financial
"The Reporting Person therefore disclaims beneficial ownership of the stock option"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Annual Meeting financial
"earlier of (i) the first anniversary of the date of grant or (ii) the date of the next Annual Meeting"
A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.
advisory fees financial
"will offset advisory fees owed by the Fund, the Nexus Fund II, and the Account"
Advisory fees are payments made to financial advisors or investment managers for guidance, portfolio management, or other services, typically charged as a fixed amount or a percentage of assets under management. They matter because they lower an investor’s net returns—like paying a mechanic to tune a car, you expect better performance, so investors weigh whether the cost is justified by higher returns, better risk control, or convenience.
separately managed account financial
"and a separately managed account (the "Account")"
A separately managed account (SMA) is a personalized investment portfolio owned by a single investor and run by a professional manager who buys and sells securities on that investor’s behalf. It matters to investors because an SMA offers tailored asset selection, tax handling, and transparency—like hiring a personal chef who prepares meals to your dietary needs rather than sharing a set menu—so you can align holdings with your goals and see exactly what you own.
FAQ
What did the PepGen (PEPG) Form 4 disclose for Joshua Resnick?
The Form 4 shows Joshua Resnick received a stock option grant for 34,000 PepGen shares at an exercise price of $1.79, expiring June 17, 2036. The grant is compensation-related and not an open-market stock purchase or sale.
How do Joshua Resnick’s PepGen (PEPG) options vest according to this filing?
The options vest in full on the earlier of the first anniversary of the grant date or the next Annual Meeting. Vesting stops if he no longer serves as a director, unless the Board determines circumstances warrant continued vesting under its discretion.
Who ultimately benefits from the PepGen (PEPG) stock option granted to Joshua Resnick?
Under an arrangement with RA Capital Management, Joshua Resnick holds the option for RA Capital Healthcare Fund, RA Capital Nexus Fund II, and a managed account. He must deliver any net cash or stock from exercise to RA Capital and disclaims beneficial ownership.
What is the exercise price and expiration date of the PepGen (PEPG) options granted?
The stock options have an exercise price of $1.79 per share and expire on June 17, 2036. These terms define the cost and time window under which the underlying PepGen common shares can be acquired upon exercise of the options.
AI-generated analysis. How Rhea-AI works. Not financial advice.
